Literature DB >> 11562533

Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene.

Dorothy N Kakoola1, Julie Sheldon2, Naomi Byabazaire3, Rory J Bowden4, Edward Katongole-Mbidde3, Thomas F Schulz2, Andrew J Davison1.   

Abstract

Human herpesvirus-8 (HHV-8) is believed to be the aetiological agent of Kaposi's sarcoma (KS). KS accounts for half the reported cancer cases in Uganda, and occurs in endemic and epidemic [human immunodeficiency virus (HIV)-associated] forms. We confirmed a high prevalence (74%) of HHV-8 antibodies in 114 HIV-negative Ugandan blood donors, and characterized the genomes of HHV-8 strains present in 30 adult Ugandan KS patients. Phylogenetic analysis of the uniquely variable K1 gene indicated that the majority of KS patients were infected by the B subtype of HHV-8, several by the A5 subtype, and one by a variant of the C subtype. Sequence analysis of nine strains at several other genome loci spaced out across the genome indicated that five are recombinants between subtypes when considered independently of previously published definitions of parental (unrecombined) genotypes. When previously published parental genotypes were taken into account, seven of the nine strains appeared to be recombinants. Analysis of the K15 gene, which exists in HHV-8 in two highly diverged alleles, indicated that the P allele predominates, with only a single strain bearing the M allele. Divergence between the M allele in the latter strain and that in the previously sequenced BC1 strain is at least as great as that between representatives of the P allele. This indicates that introduction of the M allele into extant HHV-8 subtypes did not occur by a single, relatively recent recombination event as was concluded from a previous study in which very limited variation in the M allele was reported.

Entities:  

Mesh:

Year:  2001        PMID: 11562533     DOI: 10.1099/0022-1317-82-10-2393

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation.

Authors:  Marcel Pietrek; Melanie M Brinkmann; Ilona Glowacka; Anette Enlund; Anika Hävemeier; Oliver Dittrich-Breiholz; Michael Kracht; Marc Lewitzky; Kalle Saksela; Stephan M Feller; Thomas F Schulz
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Model-based inference of recombination hotspots in a highly variable oncogene [corrected].

Authors:  G Greenspan; D Geiger; F Gotch; M Bower; S Patterson; M Nelson; B Gazzard; J Stebbing
Journal:  J Mol Evol       Date:  2004-03       Impact factor: 2.395

Review 3.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

4.  Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.

Authors:  H Kwok; C W Wu; A L Palser; P Kellam; P C Sham; D L W Kwong; A K S Chiang
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

Review 5.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

6.  Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR.

Authors:  Farnaz D Fakhari; Dirk P Dittmer
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.

Authors:  Lisa M Butler; Grant Dorsey; Wolfgang Hladik; Philip J Rosenthal; Christian Brander; Torsten B Neilands; Georgina Mbisa; Denise Whitby; Photini Kiepiela; Anisa Mosam; Similo Mzolo; Sheila C Dollard; Jeffrey N Martin
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

8.  Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Tao Kang; Feng-Chun Ye; Shou-Jiang Gao; Lin-Ding Wang
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

9.  Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes.

Authors:  Justin Stebbing; Dimitra Bourboulia; Margaret Johnson; Stephen Henderson; Ian Williams; Natalie Wilder; Mervyn Tyrer; Mike Youle; Nesrina Imami; Toru Kobu; Wolfgang Kuon; Joachim Sieper; Frances Gotch; Chris Boshoff
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Genetic diversity of the Kaposi's sarcoma herpesvirus K1 protein in AIDS-KS in Zimbabwe.

Authors:  Tiffany White; Moira Hagen; Ivy Gudza; Irene E White; Buxton Ndemera; Lovemore Gwanzura; Margaret Borok; Thomas B Campbell
Journal:  J Clin Virol       Date:  2008-04-03       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.